Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31true2023-04-014trueNo description of principal activity4false 05483238 2023-04-01 2024-03-31 05483238 2022-04-01 2023-03-31 05483238 2024-03-31 05483238 2023-03-31 05483238 c:Director4 2023-04-01 2024-03-31 05483238 d:CurrentFinancialInstruments 2024-03-31 05483238 d:CurrentFinancialInstruments 2023-03-31 05483238 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 05483238 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 05483238 d:ShareCapital 2024-03-31 05483238 d:ShareCapital 2023-03-31 05483238 d:SharePremium 2024-03-31 05483238 d:SharePremium 2023-03-31 05483238 d:RetainedEarningsAccumulatedLosses 2024-03-31 05483238 d:RetainedEarningsAccumulatedLosses 2023-03-31 05483238 c:EntityNoLongerTradingButTradedInPast 2023-04-01 2024-03-31 05483238 c:FRS102 2023-04-01 2024-03-31 05483238 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 05483238 c:FullAccounts 2023-04-01 2024-03-31 05483238 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 05483238










THE GLOBAL CLINIC - NORTHAMPTON LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
THE GLOBAL CLINIC - NORTHAMPTON LIMITED
REGISTERED NUMBER: 05483238

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 5 
199
199

Cash at bank and in hand
  
379
379

  
578
578

Creditors: amounts falling due within one year
 6 
(27,248)
(27,248)

Net current liabilities
  
 
 
(26,670)
 
 
(26,670)

Total assets less current liabilities
  
(26,670)
(26,670)

  

Net liabilities
  
(26,670)
(26,670)


Capital and reserves
  

Called up share capital 
  
1
1

Share premium account
  
125,201
125,201

Profit and loss account
  
(151,872)
(151,872)

  
(26,670)
(26,670)


Page 1

 
THE GLOBAL CLINIC - NORTHAMPTON LIMITED
REGISTERED NUMBER: 05483238
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

For the year ended 31 March 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




N McGrath
Director

Date: 30 December 2024

The notes on pages 3 to 4 form part of these financial statements.

Page 2

 
THE GLOBAL CLINIC - NORTHAMPTON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

The Global Clinic - Northampton Limited is a private company limited by shares incorporated in England and Wales in the United Kingdom. The address of the registered office is Suite 9, 20 Churchill Square, Kings Hill, West Malling, Kent, ME19 4YU.
The financial statements are presented in sterling which is the functional currency of the Company and rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

 
2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.4

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Page 3

 
THE GLOBAL CLINIC - NORTHAMPTON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

Other than those disclosed in note 2 above, there were no significant judgements made by management in preparing these financial statements.


4.


Employees

The average monthly number of employees, including directors, during the year was 4 (2023 - 4).


5.


Debtors

2024
2023
£
£


Other debtors
199
199

199
199



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
19,465
19,465

Other creditors
199
199

Accruals and deferred income
7,584
7,584

27,248
27,248



7.


Parent undertaking

The ultimate parent undertaking and parent of the smallest group for which consolidated financial statements are available is Healthshare Limited, a Company registered in England and Wales at Suite 9, 20 Churchill Square, Kings Hill, West Malling, Kent, ME19 4YU.

 
Page 4